International Scholarly Research Notices

International Scholarly Research Notices / 2013 / Article

Retraction | Open Access

Volume 2013 |Article ID 981958 | 1 page | https://doi.org/10.1155/2013/981958

Retracted: Interaction of TMPyP4, TMPyP3, and TMPyP2 with Intramolecular G-Quadruplex Formed by Promoter Region of Bcl2 and KRAS NHPPE

Received15 Mar 2013
Accepted15 Mar 2013
Published22 Mar 2013

This article has been retracted upon the authors’ request, as they have incorporated the studies of two oncogene promoter regions which form G-quadruplex complex (i.e., Bcl2 and KRAS), but the DNA considered for the studies was not from these regions. The DNA samples got mixed up, and they are from other regions of oncogene promoter. The complete ESI-MS (mass data) and the ITC (microcalorimetry data) were wrong. Since the mistake occurred at the fundamental level (i.e., at the DNA itself), the whole experiment gave wrong data. Additionally, the article was submitted for publication by the author Narayana Nagesh without the knowledge and approval of the other author Arumugam Ganesh Kumar [1].

References

  1. N. Nagesh and A. Ganesh Kumar, “Interaction of TMPyP4, TMPyP3, and TMPyP2 with intramolecular G-quadruplex formed by promoter region of Bcl2 and KRAS NHPPE,” ISRN Biophysics, vol. 2012, Article ID 786596, 12 pages, 2012. View at: Publisher Site | Google Scholar

Copyright © 2013 ISRN Biophysics. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

48 Views | 0 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.